Question 1

What are the potential side effects of HLD-0117?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer clinical trial (NCT07524855). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer clinical trial (NCT07524855). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment visits look like, and how often will I need to come in?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer clinical trial (NCT07524855). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer clinical trial (NCT07524855). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I be on this treatment if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer clinical trial (NCT07524855). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I need to provide tumor biopsies, and how will that be done?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer clinical trial (NCT07524855). Contact the study team or your healthcare provider for specific answers.

What this study is about